000 01361 a2200373 4500
005 20250511215237.0
264 0 _c19910327
008 199103s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm00106a042
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWireko, F C
245 0 0 _aAllosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cFeb 1991
300 _a758-67 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAllosteric Site
_xdrug effects
650 0 4 _aBezafibrate
_xmetabolism
650 0 4 _aChemical Phenomena
650 0 4 _aChemistry
650 0 4 _aComputers
650 0 4 _aDrug Interactions
650 0 4 _aHemoglobins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aOxygen
_xmetabolism
650 0 4 _aStereoisomerism
650 0 4 _aStructure-Activity Relationship
650 0 4 _aUrea
_xanalogs & derivatives
650 0 4 _aX-Ray Diffraction
700 1 _aKellogg, G E
700 1 _aAbraham, D J
773 0 _tJournal of medicinal chemistry
_gvol. 34
_gno. 2
_gp. 758-67
856 4 0 _uhttps://doi.org/10.1021/jm00106a042
_zAvailable from publisher's website
999 _c2002081
_d2002081